How long have we got? The accuracy of physicians’ estimates and scenarios for survival time in 898 women with recurrent ovarian cancer (ROC).

Authors

null

Felicia Roncolato

Macarthur Cancer Therapy Centre, Sydney, Australia

Felicia Roncolato , Rachel O'Connell , Florence Joly , Anne Lanceley , Felix Hilpert , Aikou Okamoto , Eriko Aotani , Sandro Pignata , Paul P. Donnellan , Amit M. Oza , Elisabeth Avall-Lundqvist , Jonathan S. Berek , Jalid Sehouli , Jonathan A. Ledermann , Dominique Berton-Rigaud , Belinda Emma Kiely , Michael Friedlander , Martin R. Stockler

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Clinical Trial Registration Number

ACTRN: 12607000603415

Citation

J Clin Oncol 37, 2019 (suppl; abstr 5549)

DOI

10.1200/JCO.2019.37.15_suppl.5549

Abstract #

5549

Poster Bd #

372

Abstract Disclosures